title: Clinical contributors to cerebral white matter integrity in HIV-infected individuals.
abstract: HIV-infected people frequently exhibit brain dysfunction characterized by preferential damage to the cerebral white matter. Despite suppressed viral load and reconstituted immune function afforded by combination antiretroviral therapy (CART), brain dysfunction continues to be observed even in medically stable individuals. To provide insight into the etiology of HIV-associated brain dysfunction in the CART era, we examined the effects of HIV disease markers, antiretroviral treatment, hepatitis C (HCV) coinfection, and age on DTI measures of white matter integrity in a cohort of 85 individuals aged 23 to 65 years with chronic HIV infection. Fractional anisotropy and mean diffusivity were derived from 29 cerebral white matter regions, which were segmented on each individual brain using a high-resolution T1-weighted image and registered to diffusion images. Significant effects of clinical variables were found on white matter abnormalities in nearly all brain regions examined. Most notably, HCV coinfection and older age were associated with decreased anisotropy or increased diffusivity in the majority of brain regions. Individuals with higher current CD4 levels exhibited higher anisotropy in parietal lobe regions, while those undergoing antiretroviral treatment exhibited higher anisotropy in temporal lobe regions. The observed diffuse pattern of white matter injury suggests that future neuroimaging studies should employ methodologies that are not limited to circumscribed regions of interest. The current findings underline the multifactorial nature of HIV-associated brain dysfunction in the CART era, and the importance of examining the effects of HIV disease in the context of other comorbidities, in particular HCV coinfection and aging.
authors.affiliation: Warren Alpert Medical School of Brown University, Providence, RI 02908, USA.
authors.forename: Assawin
authors.initials: A
authors.lastname: Gongvatana
authors.forename: Ronald A
authors.initials: RA
authors.lastname: Cohen
authors.forename: Stephen
authors.initials: S
authors.lastname: Correia
authors.forename: Kathryn N
authors.initials: KN
authors.lastname: Devlin
authors.forename: Jadrian
authors.initials: J
authors.lastname: Miles
authors.forename: Hakmook
authors.initials: H
authors.lastname: Kang
authors.forename: Hernando
authors.initials: H
authors.lastname: Ombao
authors.forename: Bradford
authors.initials: B
authors.lastname: Navia
authors.forename: David H
authors.initials: DH
authors.lastname: Laidlaw
authors.forename: Karen T
authors.initials: KT
authors.lastname: Tashima
mesh_terms: D000328:Adult; D000368:Aged; D016880:Anisotropy; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D054022:Cerebrum / Q000187:drug effects / Q000473:pathology*; D060085:Coinfection; D003430:Cross-Sectional Studies; D056324:Diffusion Tensor Imaging; D005260:Female; D006678:HIV / Q000472:pathogenicity; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D016174:Hepacivirus / Q000472:pathogenicity; D006526:Hepatitis C / Q000150:complications / Q000821:virology; D006801:Humans; D056784:Leukoencephalopathies / Q000150:complications / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D019562:Viral Load; D055815:Young Adult
chemical_list: D044966:Anti-Retroviral Agents